A transcriptional signature of fatigue derived from patients with primary Sjögren's syndrome

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  James, Katherine ^a,b   Al Ali, Shereen ^a,b,c   Tarn, Jessica ^a,b   Cockell, Simon J ^a   Gillespie, Colin S ^a   Hindmarsh, Victoria ^d   Locke, James ^b   Mitchell, Sheryl ^a,d   Lendrem, Dennis ^a,b   Bowman, Simon ^e   Price, Elizabeth ^f,ai   Pease, Colin T ^g,ad   Emery, Paul ^g,ad   Lanyon, Peter ^h   Hunter, John A ⁱ   Gupta, Monica ⁱ   Bombardieri, Michele ^j   Sutcliffe, Nurhan ^j   Pitzalis, Costantino ^j   McLaren, John ^k   Cooper, Annie ^l,m   Regan, Marian ^n,ae   Giles, Ian ^o,ap   Isenberg, David ^o,ap   Saravanan, Vadivelu ^p   Coady, David ^q   Dasgupta, Bhaskar ^r   McHugh, Neil ^s   Young Min, Steven ^m   Moots, Robert ^t   Gendi, Nagui ^u   Akil, Mohammed ^v,am   Griffiths, Bridget ^d   Hall, Frances ^y   Bacabac, Elalaine C ^t   Chadravarty, Kuntal ^z   Lamabadusuriya, Shamin ^z   Adeniba, Rashidat ^u   Hamburger, John ^aa   Richards, Andrea ^aa   Rauz, Saaeha ^ab   Brailsford, Sue ^e   Logan, Joanne ^ac   Mulherin, Diarmuid ^ac   Andrews, Jacqueline ^ad   McManus, Alison ^ad   Booth, Alison ^ae   Dimitroulas, Theodoros ^af   Kadiki, Lucy ^af   Kaur, Daljit ^af   Kitas, George ^af   Lloyd, Mark ^ag   Moore, Lisa ^ag   Gordon, Esther ^ah   Lawson, Cathy ^ah   Stirton, Lesley ⁱ   Ortiz, Gill ^ai   Clunie, Gavin ^aj   Rose, Ginny ^aj   Cuckow, Sue ^aj   Knight, Susan ^ak   Symmons, Deborah ^ak   Jones, Beverley ^ak   Carr, Andrew ^a   Collins, Katherine ^a   Corbett, Ian ^a   Downie, Christine ^a   Edgar, Suzanne ^a   Carrozzo, Marco ^a   Figuereido, Francisco ^a   Foggo, Heather ^a   Hackett, Katie ^a   Macleod, Iain ^a   Mawson, Philip ^a   Natasari, Andini ^a   Stocks, Philip ^a   Jones, Adrian ^h   Muir, Alice ^h   White, Paula ^m   Pugmire, Susan ^p   Watkins, Marianne ^l   Field, Anne ^al   Kaye, Stephen ^al   Mewar, Devesh ^al   Medcalf, Patricia ^al   Tomlinson, Pamela ^al   Whiteside, Debbie ^al   Pauling, John ^s   James, Julie ^s   Olaitan, Nike ^s   McDermott, Jayne ^am   Godia, Olivia ^am   Kidd, Elizabeth ^q   Palmer, Lynne ^q   Katsande, Victoria ^r   Long, Pamela ^r   Li, Charles ^an   Chandra, Usha ^ao   MacKay, Kirsten ^ao   Fedele, Stefano ^ap   Ferenkeh Koroma, Ada ^ap   Maconnell, Helena ^ap   Porter, Stephen ^ap   Allcoat, Paul ^k   Wipat, Anil ^a   Newton, Julia ^b,d   Jones, David E ^b   Isaacs, John ^b,w   Hallinan, Jennifer ^a,x   Ng, Wan Fai ^b,w   more..

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF BASRAH   (Iraq)

^d NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^f GREAT WESTERN HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^g UNIVERSITY OF LEEDS   (United Kingdom)

^h NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

ⁱ GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^j BARTS HEALTH NHS TRUST   (United Kingdom)

^k NHS FIFE   (United Kingdom)

^l ROYAL HAMPSHIRE COUNTY HOSPITAL   (United Kingdom)

^m PORTSMOUTH HOSPITALS NHS TRUST   (United Kingdom)

ⁿ ROYAL DERBY HOSPITAL   (United Kingdom)

^o UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^p QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^q SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

^r SOUTHEND UNIVERSITY HOSPITAL   (United Kingdom)

^s ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^t ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^u BASILDON HOSPITAL   (United Kingdom)

^v ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^w The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UK Health Security Agency   (United Kingdom)

^x Brisbane Technology Park   (Australia)

^y ADDENBROOKE S HOSPITAL   (United Kingdom)

^z HAVERING AND REDBRIDGE UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^aa BIRMINGHAM DENTAL HOSPITAL   (United Kingdom)

^ab CITY HOSPITAL   (United Kingdom)

^ac ROYAL WOLVERHAMPTON HOSPITALS NHS TRUST   (United Kingdom)

^ad CHAPEL ALLERTON HOSPITAL   (United Kingdom)

^ae DERBYSHIRE ROYAL INFIRMARY   (United Kingdom)

^af DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

^ag FRIMLEY PARK HOSPITAL   (United Kingdom)

^ah HARROGATE AND DISTRICT NHS FOUNDATION TRUST   (United Kingdom)

^ai GREAT WESTERN HOSPITAL   (United Kingdom)

^aj IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

^ak MACCLESFIELD DISTRICT GENERAL HOSPITAL   (United Kingdom)

^al ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^am Royal Sheffield Hospital   (United Kingdom)

^an Royal Surrey Hospital   (United Kingdom)

^ao TORBAY HOSPITAL   (United Kingdom)

^ap UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; DIFFERENTIALLY EXPRESSED GENE; DISEASE ASSOCIATION; FATIGUE; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE SET ENRICHMENT ANALYSIS; GENOME ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; METABOLISM; MICROARRAY ANALYSIS; MIDDLE AGED; OUTCOME ASSESSMENT; PHENOTYPE; PREDICTION; SJOEGREN SYNDROME; SUPPORT VECTOR MACHINE; AGED; AREA UNDER THE CURVE; BLOOD; COMPLICATION; DNA MICROARRAY; GENETIC PREDISPOSITION; GENETICS; PROCEDURES; SEVERITY OF ILLNESS INDEX;

TRANSCRIPTOME;

ADULT; AGED; AREA UNDER CURVE; FATIGUE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; TRANSCRIPTOME;

EID: 84957961210     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143970     Document Type: Article

References (88)

1. Cauch-Dudek K, Abbey S, Stewart DE, Heathcote EJ. Fatigue in primary biliary cirrhosis. Gut. 1998; 43: 705-710. doi: 10.1136/gut.43.5.705 PMID: 9824355
2. Huyser BA, Parker JC, Thoreson R, Smarr KL, Johnson JC, Hoffman R. Predictors of subjective fatigue among individuals with rheumatoid arthritis. Arthritis Rheum. 1998; 41: 2230-2237. doi: 10.1002/1529-0131(199812)41:12%3C2230::AID-ART19%3E3.3.CO;2-4 PMID: 9870880
3. Stone P, Richards M, Hardy J. Fatigue in patients with cancer. Eur J Cancer. 1998; 34: 1670-1676. doi: 10.1016/S0959-8049(98)00167-1 PMID: 9893650
4. Smets EM, Garssen B, Cull A, de Haes JC. Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer. 1996; 73: 241-245. doi: 10.1038/bjc.1996.42 PMID: 8546913
5. Krupp LB, LaRocca NG, Muir J, Steinberg AD. A study of fatigue in systemic lupus erythematosus. J Rheumatol. 1990; 17: 1450-1452. PMID: 2273484
6. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in multiple sclerosis. Arch Neurol. 1988; 45: 435-437. doi: 10.1001/archneur.1988.00520280085020 PMID: 3355400
7. Bower JE. Cancer-related fatigue-mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014; 11: 597-609. doi: 10.1038/nrclinonc.2014.127 PMID: 25113839
8. Irvine D, Vincent L, Graydon JE, Bubela N, Thompson L. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nurs. 1994; 17: 367-378. doi: 10.1097/00002820-199410000-00001 PMID: 7954384
9. Malik UR, Makower DF, Wadler S. Interferon-mediated fatigue. Cancer. 2001; 92: 1664-1668. doi: 10.1002/1097-0142(20010915)92:6+%3C1664::AID-CNCR1494%3E3.0.CO;2-9 PMID: 11598884
10. van't Leven M, Zielhuis GA, van der Meer JW, Verbeek AL, Bleijenberg G. Fatigue and chronic fatigue syndrome-like complaints in the general population. Eur J Public Health. 2010; 20: 251-257. doi: 10.1093/eurpub/ckp113 PMID: 19689970
11. David A, Pelosi A, McDonald E, Stephens D, Ledger D, Rathbone R, et al. Tired, weak, or in need of rest: fatigue among general practice attenders. BMJ. 1990; 301: 1199-1202. doi: 10.1136/bmj.301.6762.1199 PMID: 2261560
12. Lorusso L, Mikhaylova SV, Capelli E, Ferrari D, Ngonga GK, Ricevuti G. Immunological aspects of chronic fatigue syndrome. Autoimmun Rev. 2009; 8: 287-291. doi: 10.1016/j.autrev.2008.08.003 PMID: 18801465
13. Stone P, Hardy J, Broadley K, Tookman AJ, Kurowska A, A'Hern R. Fatigue in advanced cancer: a prospective controlled cross-sectional study. Br J Cancer. 1999; 79: 1479-1486. doi: 10.1038/sj.bjc.6690236 PMID: 10188894
14. Krupp LB, Christodoulou C. Fatigue in multiple sclerosis. Curr Neurol Neurosci Rep. 2001; 1: 294-298. doi: 10.1007/s11910-001-0033-7 PMID: 11898532
15. Burks TF. New agents for the treatment of cancer-related fatigue. Cancer. 2001; 92: 1714-1718. doi: 10.1002/1097-0142(20010915)92:6+%3C1714::AID-CNCR1502%3E3.0.CO;2-N PMID: 11598892
16. Raison CL, Lin JM, Reeves WC. Association of peripheral inflammatory markers with chronic fatigue in a population-based sample. Brain Behav Immun. 2009; 23: 327-337. doi: 10.1016/j.bbi.2008.11.005 PMID: 19111923
17. Fox RI. Sjögren's Syndrome. Lancet. 2005; 366: 321-331. doi: 10.1016/S0140-6736(05)66990-5 PMID: 16039337
18. Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, et al. Epidemiology of primary Sjögren's Syndrome: a systematic review and meta-analysis. Ann Rheum Dis. 2014 Jun 17 [Epub ahead of print]
19. Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, et al. American College of Rheumatology classification criteria for Sjögren's Syndrome: a data-driven, expert consensus approach in the Sjögren's international collaborative clinical alliance cohort. Arthritis Care Res (Hoboken). 2012; 64: 475-487. doi: 10.1002/acr.21591
20. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's Syndrome: a revised version of the european criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002; 61: 554-558. doi: 10.1136/ard.61.6.554 PMID: 12006334
21. Brkic Z, Maria NI, van Helden-Meeuwsen CG, van de Merwe JP, van Daele PL, Dalm VA, et al. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjögren's Syndrome and association with disease activity and BAFF gene expression. Ann Rheum Dis. 2013; 72: 728-35. doi: 10.1136/annrheumdis-2012-201381 PMID: 22736090
22. Ng WF, Bowman SJ. Primary Sjögren's Syndrome: too dry and too tired. Rheumatology (Oxford). 2010; 49: 844-853. doi: 10.1093/rheumatology/keq009
23. Barendregt PJ, Visser MR, Smets EM, Tulen JH, van den Meiracker AH, Boomsma F, et al. Fatigue in primary Sjögren's Syndrome. Ann Rheum Dis. 1998; 57: 291-5. doi: 10.1136/ard.57.5.291 PMID: 9741313
24. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdóttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011; 27: 1739-1740. doi: 10.1093/bioinformatics/btr260 PMID: 21546393
25. Nishimura D. BioCarta. Biotech Software & Internet Report. 2001; 2:117-120. doi: 10.1089/152791601750294344
26. Vastrik I, D'Eustachio P, Schmidt E, Joshi-Tope G, Gopinath G, Croft D, et al. Reactome: a knowledge base of biologic pathways and processes. Genome Biol. 2007; 8: R39. doi: 10.1186/gb-2007-8-3-r39 PMID: 17367534
27. Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000; 28:27-30. doi: 10.1093/nar/28.1.27 PMID: 10592173
28. Segal B, Thomas W, Rogers T, Leon JM, Hughes P, Patel D, et al. Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren's Syndrome. Arthritis Rheum. 2008; 59: 1780-7. doi: 10.1002/art.24311 PMID: 19035421
29. Bowman SJ, Booth DA, Platts RG, UK Sjögren's Interest Group. Measurement of fatigue and discomfort in primary Sjögren's Syndrome using a new questionnaire tool. Rheumatology (Oxford). 2004; 43: 758-764. doi: 10.1093/rheumatology/keh170
30. Strömbeck B, Ekdahl C, Manthorpe R, Jacobsson LT. Physical capacity in women with primary Sjögren's Syndrome: a controlled study. Arthritis Rheum. 2003; 49: 681-8. doi: 10.1002/art.11384 PMID: 14558054
31. Emamian ES, Leon JM, Lessard CJ, Grandits M, Baechler EC, Gaffney PM, et al. Peripheral blood gene expression profiling in Sjögren's Syndrome. Genes Immun. 2009; 10: 285-96. doi: 10.1038/gene.2009.20 PMID: 19404300
32. Wildenberg ME, van Helden-Meeuwsen CG, van de Merwe JP, Drexhage HA, Versnel MA. Systemic increase in type I interferon activity in Sjögren's Syndrome: a putative role for plasmacytoid dendritic cells. Eur J Immunol. 2008; 38: 2024-33. doi: 10.1002/eji.200738008 PMID: 18581327
33. Gottenberg JE, Cagnard N, Lucchesi C, Letourneur F, Mistou S, Lazure T, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's Syndrome. Proc Natl Acad Sci USA. 2006; 103: 2770-5. doi: 10.1073/pnas.0510837103 PMID: 16477017
34. Hjelmervik TO, Petersen K, Jonassen I, Jonsson R, Bolstad AI. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's Syndrome patients from healthy control subjects. Arthritis Rheum. 2005; 52: 1534-44. doi: 10.1002/art.21006 PMID: 15880807
35. Byrnes A, Jacks A, Dahlman-Wright K, Evengard B, Wright FA, Pedersen NL, et al. Gene expression in peripheral blood leukocytes in monozygotic twins discordant for chronic fatigue: no evidence of a biomarker. PLoS One. 2009; 4: e5805. doi: 10.1371/journal.pone.0005805 PMID: 19503787
36. Landmark-Høyvik H, Reinertsen KV, Loge JH, Fosså SD, Børresen-Dale AL, Dumeaux V. Alterations of gene expression in blood cells associated with chronic fatigue in breast cancer survivors. Pharmacogenomics J. 2009; 9: 333-40. doi: 10.1038/tpj.2009.27 PMID: 19546881
37. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005; 102: 15545-15550. doi: 10.1073/pnas.0506580102 PMID: 16199517
38. Jones GE. Cellular signaling in macrophage migration and chemotaxis. J Leukoc Biol. 2000; 68: 593-602. PMID: 11073096
39. Pihur V, Datta S, Datta S. Meta analysis of chronic fatigue syndrome through integration of clinical, gene expression, SNP and proteomic data. Bioinformation. 2011; 6: 120-4. doi: 10.6026/97320630006120 PMID: 21584188
40. Eden S, Rohatgi R, Podtelejnikov AV, Mann M, Kirschner MW. Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck. Nature. 2002; 418: 790-3. doi: 10.1038/nature00859 PMID: 12181570
41. Zhu Y, Bond J, Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA. 2003; 100: 2237-42. doi: 10.1073/pnas.0436133100 PMID: 12601167
42. Cotta-de-Almeida V, Westerberg L, Maillard MH, Onaldi D, Wachtel H, Meelu P, et al. Wiskott Aldrich syndrome protein (WASP) and N-WASP are critical for T cell development. Proc Natl Acad Sci USA. 2007; 104: 15424-9. doi: 10.1073/pnas.0706881104 PMID: 17878299
43. Welch MD, DePace AH, Verma S, Iwamatsu A, Mitchison TJ. The human Arp2/3 complex is composed of evolutionarily conserved subunits and is localized to cellular regions of dynamic actin filament assembly. J Cell Biol. 1997; 138: 375-84. doi: 10.1083/jcb.138.2.375 PMID: 9230079
44. Kerr JR, Petty R, Burke B, Gough J, Fear D, Sinclair LI, et al. Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Infect Dis. 2008; 197: 1171-1184. doi: 10.1086/533453 PMID: 18462164
45. Zhang L, Gough J, Christmas D, Mattey DL, Richards SC, Main J, et al. Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis. J Clin Pathol. 2010; 63: 156-64. doi: 10.1136/jcp.2009.072561 PMID: 19955554
46. Frampton D, Kerr J, Harrison TJ, Kellam P. Assessment of a 44 gene classifier for the evaluation of chronic fatigue syndrome from peripheral blood mononuclear cell gene expression. PLoS One. 2011; 6: e16872. doi: 10.1371/journal.pone.0016872 PMID: 21479222
47. Gow JW, Hagan S, Herzyk P, Cannon C, Behan PO, Chaudhuri A. A gene signature for post-infectious chronic fatigue syndrome. BMC Med Genomics. 2009; 2: 38-38. doi: 10.1186/1755-8794-2-38 PMID: 19555476
48. Wang Y, Li Y, Shi G. The regulating function of heterotrimeric G proteins in the immune system. Arch Immunol Ther Exp (Warsz). 2013; 61: 309-19. doi: 10.1007/s00005-013-0230-5
49. Light KC, Agarwal N, Iacob E, White AT, Kinney AY, VanHaitsma TA, et al. Differing leukocyte gene expression profiles associated with fatigue in patients with prostate cancer versus chronic fatigue syndrome. Psychoneuroendocrinology. 2013; 12: 2983-95. doi: 10.1016/j.psyneuen.2013.08.008
50. Light AR, Bateman L, Jo D, Hughen RW, VanHaitsma TA, White AT, et al. Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome. Journal of Internal Medicine. 2012; 1: 64-81. doi: 10.1111/j.1365-2796.2011.02405.x
51. Staines D. Are vasoactive neuropeptide autoimmune fatigue-related disorders mediated via G-protein-coupled receptors? Med Hypotheses. 2005; 65: 29-31. doi: 10.1016/j.mehy.2005.02.013 PMID: 15893112
52. Smith AK, Fang H, Whistler T, Unger ER, Rajeevan MS. Convergent genomic studies identify association of GRIK2 and NPAS2 with chronic fatigue syndrome. Neuropsychobiology. 2011; 64: 183-94. doi: 10.1159/000326692 PMID: 21912186
53. Beuschlein F, Fassnacht M, Assié G, Calebiro D, Stratakis CA, Osswald A, et al. Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. N Engl J Med. 2014; 370: 1019-28. doi: 10.1056/NEJMoa1310359 PMID: 24571724
54. Schappi JM, Krbanjevic A, Rasenick MM. Tubulin, actin and heterotrimeric G proteins: coordination of signaling and structure. Biochim Biophys Acta. 2014; 1838: 674-81. doi: 10.1016/j.bbamem.2013.08.026 PMID: 24071592
55. Carlson KE, Woolkalis MJ, Newhouse MG, Manning DR. Fractionation of the beta subunit common to guanine nucleotide-binding regulatory proteins with the cytoskeleton. Mol Pharmacol. 1986; 30: 463-8. PMID: 3095628
56. Harhammer R, Gohla A, Schultz G. Interaction of G protein Gβγ dimers with small GTP-binding proteins of the Rho family. FEBS Lett. 1996; 399: 211-4. doi: 10.1016/S0014-5793(96)01327-0 PMID: 8985147
57. Kameoka J, Tanaka T, Nojima Y, Schlossman SF, Morimoto C. Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science. 1993; 261: 466-9. doi: 10.1126/science.8101391 PMID: 8101391
58. Baraniuk JN, Jamieson MJ. Rhinorrhea, cough and fatigue in patients taking sitagliptin. Allergy Asthma Clin Immunol. 2010; 6: 8. doi: 10.1186/1710-1492-6-8 PMID: 20462426
59. Tejera-Alhambra M, Casrouge A, de Andrés C, Ramos-Medina R, Alonso B, Vega J, et al. Low DPP4 expression and activity in multiple sclerosis. Clin Immunol. 2014; 150: 170-83. doi: 10.1016/j.clim.2013.11.011 PMID: 24412911
60. Fletcher MA, Zeng XR, Maher K, Levis S, Hurwitz B, Antoni M, et al. Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26. PLoS One. 2010; 5: e10817. doi: 10.1371/journal.pone.0010817 PMID: 20520837
61. Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol. 1990; 28: 1403-10. PMID: 2166084
62. Rosenbaum M, Leibel RL. 20 years of leptin: role of leptin in energy homeostasis in humans. J Endocrinol. 2014; 223: T83-96. doi: 10.1530/JOE-14-0358 PMID: 25063755
63. Stringer EA, Baker KS, Carroll IR, Montoya JG, Chu L, Maecker HT, et al. Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology. J Transl Med. 2013; 11: 93. doi: 10.1186/1479-5876-11-93 PMID: 23570606
64. Piche T, Gelsi E, Schneider SM, Hébuterne X, Giudicelli J, Ferrua B, et al. Fatigue is associated with high circulating leptin levels in chronic hepatitis C. Gut. 2002; 51: 434-9. doi: 10.1136/gut.51.3.434 PMID: 12171970
65. Scholköpf C, Burger CJC, Smola AJ. Advances in Kernel Methods. MIT Press, Cambridge, MA; 1999.
66. Reeves WC, Lloyd A, Vernon SD, Klimas N, Jason LA, Bleijenberg G, et al. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res. 2003; 3: 25-25. doi: 10.1186/1472-6963-3-25 PMID: 14702202
67. Ng WF, Bowman SJ, Griffiths B, UKPSSR study group. United Kingdom primary Sjögren's Syndrome registry-a united effort to tackle an orphan rheumatic disease. Rheumatology (Oxford). 2011; 50: 32-39. doi: 10.1093/rheumatology/keq240
68. GLOBINclear Kit (Cat #AM1980, AM1981) Instruction Manual. https://tools.lifetechnologies.com/content/sfs/manuals/fm-1980.pdf
69. Lee K, Hicks G, Nino-Murcia G. Validity and reliability of a scale to assess fatigue. Psychiatry Res. 1991; 3: 291-298. doi: 10.1016/0165-1781(91)90027-M
70. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67: 361-370. doi: 10.1111/j.1600-0447.1983.tb09716.x PMID: 6880820
71. Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A, et al. Eular Sjögren's Syndrome patient reported index (ESSPRI): development of a consensus patient index for primary Sjögren's Syndrome. Ann Rheum Dis. 2011; 70: 968-972. doi: 10.1136/ard.2010.143743 PMID: 21345815
72. Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, et al. Eular Sjögren's Syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's Syndrome. Ann Rheum Dis. 2010; 69: 1103-1109. doi: 10.1136/ard.2009.110619 PMID: 19561361
73. Vitali C, Palombi G, Baldini C, Benucci M, Bombardieri S, Covelli M, et al. Sjögren's Syndrome disease damage index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's Syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum. 2007; 56: 2223-2231. doi: 10.1002/art.22658 PMID: 17599741
74. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004; 5: R80. doi: 10.1186/gb-2004-5-10-r80 PMID: 15461798
75. Cockell S, Bashton M, Gillespie C. Bioconductor tools for microarray data analysis. In: Microarray Image and Data Analysis Theory and Practice, CRC Press; 2014. pp. 459-479.
76. Du P, Kibbe WA, Lin SM. lumi: a pipeline for processing Illumina microarray. Bioinformatics. 2008; 24: 1547-1548. doi: 10.1093/bioinformatics/btn224 PMID: 18467348
77. Kauffmann A, Gentleman R, Huber W. arrayQualityMetrics-a Bioconductor package for quality assessment of microarray data. Bioinformatics. 2009; 25: 415-416. doi: 10.1093/bioinformatics/btn647 PMID: 19106121
78. Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007; 8: 118-127. doi: 10.1093/biostatistics/kxj037 PMID: 16632515
79. Carlson, M lumiHumanAll.db: R package version 1.22.0.
80. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004; 3: article 3. PMID: 16646809
81. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. R Statist Soc. 1995; 57: 289-30.
82. Kirou KA, Lee C, George S, Louca K, Papagiannis IG, Peterson MG, et al. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum. 2004; 50: 3958-67. doi: 10.1002/art.20798 PMID: 15593221
83. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003; 34: 267-273. doi: 10.1038/ng1180 PMID: 12808457
84. Cortes C, Vapnik V. Support-vector networks. Machine Learning. 1995; 20: 273. doi: 10.1023/A:1022627411411
85. Meyer, D Support vector machines - the interface to libsvm in package e1071. R documentation Available: urlhttp://cran.r-project.org/web/packages/e1071/index.html; 2014.
86. Kuhn M. caret: classification and regression training. R package version 6.0-35. Available: http://CRAN.R-project.org/package=caret; 2014.
87. Henderson AR. Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis. Ann Clin Biochem. 1993; 30:521-539. doi: 10.1177/000456329303000601 PMID: 8304720
88. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982; 143:29-36. doi: 10.1148/radiology.143.1.7063747 PMID: 7063747